ArticleLife (Basel, Switzerland)2023

Real-World Data on Second-Line Therapy with Ramucirumab for Metastatic Gastric Cancer: A Two-Center Study on Romanian Population.

Diana Galos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.